ADVERTISEMENT
Search

Pharmacy News

What strategies do pharmacists use to identify and prevent adverse drug reactions?

In what is believed to be the first study of its kind, researchers examined the cognitive processes health care professionals use to detect, resolve, and monitor adverse drug reactions.

Drug overdose deaths from nonbenzodiazepine sleeping pills and anti-epilepsy gabapentinoids rises

A new study in The Lancet Regional Health Americas found that the proportion of overdose deaths involving nonbenzodiazepine sleeping drugs (also called z-drugs) and anti-epilepsy gabapentinoids increased more than threefold between 2000 and 2018, coinciding with exponential prescription increases since their introduction into the market.

New report shows 82% of patients still experience medication delays

A new report estimates that 82% of patients experienced medication delays in the last year because of COVID-19 restrictions, prescriptions cost, communication challenges, insurance processes, and/or lack of transportation.

FDA aims to develop nonaddictive alternative to opioids

FDA issued draft guidance about its plan to develop nonopioid analgesics for acute pain in an effort to spur the development of nonaddictive alternatives.FDA issued draft guidance about its plan to develop nonopioid analgesics for acute pain in an effort to spur the development of nonaddictive alternatives.

USP releases new chapter <797> proposals

The United States Pharmacopeia (USP) has finally released its updated Chapter <797> revisions. These revisions were written over the past 22 months while USP considered appeals filed by stakeholders. The 2019 version is mostly intact in the revision, but there are some changes to beyond-use dates (BUD) for certain institutions. In addition, USP clarifies when to identify microorganisms found during various sampling activities.

RSS
First3738394042444546Last
ADVERTISEMENT